ClinicalTrials.gg
CompletedNCT03389945Updated Jun 4, 2020

Different Spinal Needles Sizes and Dural Puncture Epidural For Labor Analgesia

An interventional study of 25G Dural Puncture Epidural Block and 27G Dural Puncture Epidural Block in Labor Pain and Epidural Analgesia, sponsored by University of Chile. Completed at 2 sites in Chile. Open to female participants. Per ClinicalTrials.gov, last updated 2020-06-04.

Sponsored by University of Chile · Not applicable, Interventional, and Supportive care

Phase
Not applicable
Study type
Interventional
Enrollment
140
Allocation
Randomized
Sex
Female
01

Study summary

The rationale behind the dural puncture epidural (DPE) technique lies in the fact that a dural perforation with a spinal needle purportedly creates a conduit for accelerated translocation of local anesthetics from the epidural to the subarachnoid space. When compared with conventional epidural block, it provides improved sacral block and onset of analgesia.

Despite the benefits associated, the supportive literature remains scarce. No trial has determined if similar results could be obtained with a smaller needle.

In this trial, DPE using 25- and 27-gauge (G) spinal needles are compared. The main outcome will be the time required to obtain a pain score ≤ 1 using a 0-10 numeric rating scale (NRS). The hypothesis is that that both needle sizes will result in similar onset times and therefore designing the current study as an equivalence trial.

02

Conditions studied

  • Labor Pain
  • Epidural Analgesia

Keywords

  • Labor analgesia
  • Dural puncture epidural
  • Postdural puncture headache
  • Neuraxial analgesia
03

In context

Labor Pain

423 studies on the registry are indexed under Labor Pain; 74 are open to participants now.

This study's enrollment of 140 is above the median of 100 across 347 interventional studies indexed under Labor Pain.

Browse Labor Pain studies →

Lead sponsor

University of Chile is the lead sponsor of 194 studies on the registry; 38 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
Child (0–17), Adult (18–64), Older adult (65+)
Sexes eligible
Female
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • healthy pregnant woman
  • singleton and vertex presentation
  • 37-42 weeks of gestational age
  • active labor with cervical dilation \< 5cm
  • between 20 and 35 kg/m2
  • desired labor epidural analgesia

Exclusion criteria

Exclusion Criteria:

  • adults who are unable to give their own consent
  • presence of any pregnancy-related disease (e.g., gestational hypertension, preeclampsia, gestational diabetes)
  • known fetal anomalies
  • increased risk of cesarean delivery (e.g., previous uterine rupture, previous cesarean delivery)
  • coagulopathy (assessed by history and physical examination and, if deemed clinically necessary, by blood work up i.e. ≤ 100, ≥ 1.4 or partial prothrombin time ≥ 50)
  • renal failure (assessed by history and physical examination and, if deemed clinically necessary, by blood work up i.e. creatinine ≥ 100)
  • hepatic failure (assessed by history and physical examination and, if deemed clinically necessary, by blood work up i.e. transaminases ≥ 100)
  • allergy to LA
  • prior sacral or lumbar spine surgery
Terms in these criteria, in plain language(3)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

BMI (body mass index)

Weight in kilograms divided by height in metres squared. Example: 70 kg and 1.75 m gives 70 ÷ (1.75 × 1.75) ≈ 22.9.

What counts as overweight or obesity differs between countries (some use lower cut-offs), so go by the range the study states.

Platelets

Blood cells that help blood clot. Too few raises the risk of bleeding and bruising. A usual adult range is about 150–400 × 10⁹/L (150,000–400,000 per µL); each lab has its own reference range.

INR, PT and aPTT (clotting tests)

Blood tests of how long blood takes to clot. The INR is the prothrombin time (PT) put on a common scale; about 1 is usual for someone not taking a blood thinner.

Criteria often make an exception for people on a blood thinner such as warfarin, whose INR is raised on purpose.

05

Study design

Phase
Not applicable
Primary purpose
Supportive care
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Triple (Participant, Investigator, Outcomes assessor)
Enrollment
140 participants (actual)

Study arms

  • Active comparator
    25G Dural Puncture Epidural Block

    Patients will receive a dural puncture epidural block with a 25 gauge spinal needle.

    Procedure: 25G Dural Puncture Epidural Block

  • Experimental
    27G Dural Puncture Epidural Block

    Patients will receive a dural puncture epidural block with a 27 gauge spinal needle.

    Procedure: 27G Dural Puncture Epidural Block

Interventions

  • Procedure25G Dural Puncture Epidural Block

    Dural puncture epidural analgesia using a 25G pencil point spinal needle at a lumbar interspace. Then 20ml of bupivacaine 0.125% + fentanyl 2ug/ml will be injected in the epidural space.

  • Procedure27G Dural Puncture Epidural Block

    Dural puncture epidural analgesia using a 27G pencil point spinal needle at a lumbar interspace. Then 20ml of bupivacaine 0.125% + fentanyl 2ug/ml will be injected in the epidural space.

06

What researchers measure

Primary outcomes

  1. Time to pain ≤ 1 on NRS (0-10)

    Time elapsed between the end of local anesthetic injection and achievement of pain ≤ 1 on the NRS (measured every 2 minutes)

    Time frame: Up to 30 minutes after local anesthetic injection

Secondary outcomes

  1. Gestational age

    Gestational age at the time of recruitment

    Time frame: 42 weeks

  2. Obstetric history

    Number of previous pregnancies and deliveries

    Time frame: At the time of recruitment

  3. Type of labor

    Spontaneous versus induced labor

    Time frame: At the time of delivery

  4. Oxytocin dose

    Oxytocin infusion/dose at time of DPE

    Time frame: At the time of DPE

  5. Cervical dilation

    Cervical dilation at the time of DPE

    Time frame: At the time of DPE

  6. State of membrane

    Intact versus ruptured membrane at the time of DPE

    Time frame: At the time of DPE

  7. Pre-DPE level of pain

    Evaluated with a NRS from 0 to 10

    Time frame: Immediate before DPE

  8. Amount of IV fluids

    Total intravenous fluid received during labor (from admission to the obstetric suite up to delivery)

    Time frame: 24 hours

  9. Intervertebral level of puncture

    Lumbar interspace where DPE was successfully performed

    Time frame: At the time of DPE

  10. Number of DPE attempts

    Number of attempts for successful DPE

    Time frame: 1 hour

  11. Incidence of accidental dural puncture

    Incidence of accidental dural puncture with the epidural Tuohy needle

    Time frame: 1 hour

  12. Performance time

    Temporal interval between skin disinfection and epidural catheter fixation to the skin

    Time frame: 1 hour

  13. Sensory block height

    Sensory block height at 30 minutes after local anesthetic injection

    Time frame: Up to 30 minutes after local anesthetic injection

  14. Bilateral S2 sacral root block

    Measured every 2 minutes after local anesthetic injection

    Time frame: Up to 30 minutes after local anesthetic injection

  15. Presence of motor block

    Evaluated using a modified Bromage score

    Time frame: Up to 30 minutes after local anesthetic injection

  16. Number of epidural top-ups during labor

    Number of extra doses of local anesthetic given after DPE up to delivery

    Time frame: After DPE up to delivery

  17. Type of delivery

    Incidence of Cesarean section, normal delivery, and instrumented delivery

    Time frame: Delivery

  18. Incidence of epidural catheter adjustment or replacement

    Necessity of adjustment or replacement of the epidural catheter

    Time frame: After DPE up to delivery

  19. DPE side effects

    Incidence of nausea, pruritus, hypotension

    Time frame: After DPE up to delivery

  20. Fetal-Uterine assessment

    Frequency of contractions, uterine tonus, fetal heart rate tracing

    Time frame: Before and up to 1 hour after DPE

  21. Tocolysis requirement

    Necessity to administer a tocolytic agent after DPE

    Time frame: Up to 1 hour after DPE

  22. Apgar scores

    Assessment of newborn condition

    Time frame: At 1 and 5 minutes after delivery

  23. DPE complications

    Incidence of post dural puncture headache, back pain, paresthesia and motor deficit

    Time frame: After DPE up to 7 days postpartum

  24. Epidural blood patch incidence

    Necessity of performing of a blood patch to relieve post dural puncture headache symptoms

    Time frame: Up to 1 week of followup

Other outcomes

  1. Demographic data

    Age, height, weight, BMI

    Time frame: At the time of recruitment

07

Study locations

2 sites
  • Hospital Clínico Universidad de Chile
    Santiago, Metropolitana, Chile
  • Hospital La Florida
    Santiago, Región Metropolitana, Chile
08

References and documents

Publications

  • Suzuki N, Koganemaru M, Onizuka S, Takasaki M. Dural puncture with a 26-gauge spinal needle affects spread of epidural anesthesia. Anesth Analg. 1996 May;82(5):1040-2. doi: 10.1097/00000539-199605000-00028. PubMed 8610864 ↗
  • Cappiello E, O'Rourke N, Segal S, Tsen LC. A randomized trial of dural puncture epidural technique compared with the standard epidural technique for labor analgesia. Anesth Analg. 2008 Nov;107(5):1646-51. doi: 10.1213/ane.0b013e318184ec14. PubMed 18931227 ↗
  • Chau A, Bibbo C, Huang CC, Elterman KG, Cappiello EC, Robinson JN, Tsen LC. Dural Puncture Epidural Technique Improves Labor Analgesia Quality With Fewer Side Effects Compared With Epidural and Combined Spinal Epidural Techniques: A Randomized Clinical Trial. Anesth Analg. 2017 Feb;124(2):560-569. doi: 10.1213/ANE.0000000000001798. PubMed 28067707 ↗
  • Tran DQ, Van Zundert TC, Aliste J, Engsusophon P, Finlayson RJ. Primary Failure of Thoracic Epidural Analgesia in Training Centers: The Invisible Elephant? Reg Anesth Pain Med. 2016 May-Jun;41(3):309-13. doi: 10.1097/AAP.0000000000000394. PubMed 27035462 ↗
  • Thomas JA, Pan PH, Harris LC, Owen MD, D'Angelo R. Dural puncture with a 27-gauge Whitacre needle as part of a combined spinal-epidural technique does not improve labor epidural catheter function. Anesthesiology. 2005 Nov;103(5):1046-51. doi: 10.1097/00000542-200511000-00019. PubMed 16249679 ↗
  • Landau R, Ciliberto CF, Goodman SR, Kim-Lo SH, Smiley RM. Complications with 25-gauge and 27-gauge Whitacre needles during combined spinal-epidural analgesia in labor. Int J Obstet Anesth. 2001 Jul;10(3):168-71. doi: 10.1054/ijoa.2000.0834. PubMed 15321605 ↗
  • Beilin Y, Zahn J, Bernstein HH, Zucker-Pinchoff B, Zenzen WJ, Andres LA. Treatment of incomplete analgesia after placement of an epidural catheter and administration of local anesthetic for women in labor. Anesthesiology. 1998 Jun;88(6):1502-6. doi: 10.1097/00000542-199806000-00013. PubMed 9637643 ↗
  • Contreras F, Morales J, Bravo D, Layera S, Jara A, Riano C, Pizarro R, De La Fuente N, Aliste J, Finlayson RJ, Tran DQ. Dural puncture epidural analgesia for labor: a randomized comparison between 25-gauge and 27-gauge pencil point spinal needles. Reg Anesth Pain Med. 2019 May 22:rapm-2019-100608. doi: 10.1136/rapm-2019-100608. Online ahead of print. PubMed 31118278 ↗

Individual participant data

Plan to share: No

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Ran from Jan 2018 to primary completion in Mar 2019, 13 months.

Of 191 non-industry interventional studies with no phase under Labor Pain, half reached primary completion within 9 months of starting (the median), counting those still running; a quarter within 5 and three quarters within 14. This study's 13 months is above that.

Counting every sponsor, half of 193 studies reached it within 9 months; a quarter within 5 and three quarters within 14.

How these figures are worked out, and which studies are left out of them.

Registered
Dec 14, 2017
First posted
Jan 4, 2018
StartActual
Jan 13, 2018
Primary completionActual
Mar 12, 2019
CompletionActual
Mar 19, 2019
Last update
Jun 4, 2020
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Jun 4, 2020, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT03389945
Responsible party
Felipe Contreras Godoy (Clinical Instructor, Department of Anesthesia, University of Chile) — Principal investigator
First posted
Jan 4, 2018
Start date
Jan 13, 2018
Primary completion
Mar 12, 2019
Completion
Mar 19, 2019
Last update
Jun 4, 2020

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Jun 2020. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion